- Home
- ISSC vs CRDF Comparison
ISSC vs CRDF Comparison
Compare ISSC & CRDF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ISSC
- CRDF
- Stock Information
- Founded
- ISSC 1988
- CRDF 1999
- Country
- ISSC United States
- CRDF United States
- Employees
- ISSC N/A
- CRDF N/A
- Industry
- ISSC EDP Services
- CRDF Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ISSC Technology
- CRDF Health Care
- Exchange
- ISSC Nasdaq
- CRDF Nasdaq
- Market Cap
- ISSC 155.7M
- CRDF 152.3M
- IPO Year
- ISSC 2000
- CRDF N/A
- Fundamental
- Price
- ISSC $8.60
- CRDF $2.15
- Analyst Decision
- ISSC
- CRDF Strong Buy
- Analyst Count
- ISSC 0
- CRDF 4
- Target Price
- ISSC N/A
- CRDF $10.63
- AVG Volume (30 Days)
- ISSC 371.7K
- CRDF 723.0K
- Earning Date
- ISSC 12-18-2025
- CRDF 11-06-2025
- Dividend Yield
- ISSC N/A
- CRDF N/A
- EPS Growth
- ISSC 78.33
- CRDF N/A
- EPS
- ISSC 0.66
- CRDF N/A
- Revenue
- ISSC $77,434,581.00
- CRDF $501,000.00
- Revenue This Year
- ISSC $71.55
- CRDF N/A
- Revenue Next Year
- ISSC $15.19
- CRDF N/A
- P/E Ratio
- ISSC $13.07
- CRDF N/A
- Revenue Growth
- ISSC 72.82
- CRDF N/A
- 52 Week Low
- ISSC $5.30
- CRDF $1.90
- 52 Week High
- ISSC $20.00
- CRDF $5.64
- Technical
- Relative Strength Index (RSI)
- ISSC 28.71
- CRDF 43.50
- Support Level
- ISSC $8.70
- CRDF $2.06
- Resistance Level
- ISSC $9.06
- CRDF $2.33
- Average True Range (ATR)
- ISSC 0.34
- CRDF 0.11
- MACD
- ISSC -0.02
- CRDF -0.01
- Stochastic Oscillator
- ISSC 2.83
- CRDF 25.00
About ISSC Innovative Solutions and Support Inc.
Innovative Solutions and Support Inc is a systems integrator that designs, manufactures, sells, and services air data equipment, engine display systems, standby equipment, primary flight guidance, and cockpit display systems for retrofit applications and original equipment manufacturers. The company supplies integrated Flight Management Systems, Flat Panel Display Systems, Integrated Standby Units, Positioning System receivers that enable reduced carbon footprint navigation, and an Autothrottle, which allows a pilot to automatically control the power setting of the engine and is designed to reduce pilot workload and enhance safety. It sells its products to both the OEM and the retrofit markets.
About CRDF Cardiff Oncology Inc.
Cardiff Oncology Inc is a clinical-stage biotechnology company leveraging PLK1 inhibition, a well-validated oncology drug target, to develop novel therapies across a range of cancers with the greatest unmet medical need. It is focusing on clinical programs in indications such as RAS-mutated metastatic colorectal cancer ("mCRC"), as well as in investigator-initiated trials in metastatic pancreatic ductal adenocarcinoma ("mPDAC"), small cell lung cancer ("SCLC"), and triple negative breast cancer ("TNBC"). Geographically, the company only operates in the United States.